RDHL
Redhill Biopharma·NASDAQ
--
--(--)
--
--(--)
RDHL fundamentals
Redhill Biopharma (RDHL) released its earnings on Aug 17, 2023: revenue was -- (YoY --), beat estimates; EPS was -- (YoY --), met estimates.
Revenue / YoY
--
--
EPS / YoY
--
--
Report date
Aug 17, 2023
EPS
Actual | -500 | -400 | -500 | -650 | -500 | -600 | -500 | -500 | -30 | -20 | -60 | -1.25 | ||||||||||||
Forecast | -690 | -137.5 | -270 | -346 | -435 | -352.8571 | -474.2857 | -433.3333 | -300 | -20 | -10 | 0 | ||||||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +27.54% | -190.91% | -85.19% | -87.86% | -14.94% | -70.04% | -5.42% | -15.38% | +90.00% | 0.00% | -500.00% | 0.00% | 0.00% | 0.00% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.06M | 20.90M | 20.94M | 21.46M | 20.57M | 21.50M | 21.60M | 22.10M | 18.24M | 18.35M | 17.55M | -- | 3.60M | -- |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 4.38M | 22.99M | 25.36M | 26.04M | 22.70M | 24.29M | 24.51M | 24.09M | 23.60M | 21.50M | 18.50M | 18.10M | -- | -- |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -75.88% | -9.10% | -17.42% | -17.59% | -9.37% | -11.46% | -11.89% | -8.25% | -22.73% | -14.68% | -5.12% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What does Redhill Biopharma do and what are its main business segments?What is Redhill Biopharma's gross profit margin?What is Redhill Biopharma's latest dividend and current dividend yield?What is the market's earnings forecast for Redhill Biopharma next quarter?What is the revenue and EPS growth rate for Redhill Biopharma year over year?What factors drove the changes in Redhill Biopharma's revenue and profit?What guidance did Redhill Biopharma's management provide for the next earnings period?What were the key takeaways from Redhill Biopharma's earnings call?
